MarDee Haring-Layton - 04 Sep 2025 Form 4 Insider Report for Dare Bioscience, Inc. (DARE)

Role: Chief Accounting Officer
Signature: /s/ MarDee Haring-Layton
Issuer symbol: DARE
Transactions as of: 04 Sep 2025
Net transactions value: $0
Form type: 4
Filing time: 04 Sep 2025, 17:59:23 UTC
Previous filing: 31 Jan 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Haring-Layton MarDee	Chief Accounting Officer	C/O DARE BIOSCIENCE, INC., 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO	/s/ MarDee Haring-Layton	04 Sep 2025	0001535596

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DARE	Employee Stock Option (right to buy)	Award	$0	+57,000		$0.000000	57,000	04 Sep 2025	Common stock	57,000	$2.13	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This stock option was granted to the reporting person as a retention award and vests and becomes exercisable on 9/4/2027, provided, that, if certain performance criteria are satisfied, it will vest and become exercisable on the date such performance criteria are satisfied, subject to the reporting person's continuous service to the issuer.